NetworkNewsBreaks – Therma Bright, Inc. (TSX.V:
Post# of 62
(Total Views: 329)
Posted On: 01/09/2019 3:49:20 PM
NetworkNewsBreaks – Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) Combining its Thermal Therapy Technology with CBD to Target Chronic Pain
Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) is developing an innovative pain relief therapy that utilizes its thermal therapy technology in combination with medical grade cannabis or cannabidiol (“CBD”) from hemp in the form of a cream or gel. A recent article discussing the company reads, “In October, Therma Bright revealed that it is also developing testing for a hemp cannabidiol (CBD)-based pain relief therapy that will use creams, gels or salves in concert with its thermal-generation products to target various forms of general or chronic pain such as back pain, arthritic pain and other orthopedic concerns. The company announced its first prototype in December. … Therma Bright’s attention to such a variety of skin care concerns positions it well within the cosmeceuticals market, which is expected to grow at a CAGR of 8.21 percent between 2017 and 2023, resulting in a worldwide market valued at $72.99 billion overall (http://nnw.fm/k91bY). ”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) is developing an innovative pain relief therapy that utilizes its thermal therapy technology in combination with medical grade cannabis or cannabidiol (“CBD”) from hemp in the form of a cream or gel. A recent article discussing the company reads, “In October, Therma Bright revealed that it is also developing testing for a hemp cannabidiol (CBD)-based pain relief therapy that will use creams, gels or salves in concert with its thermal-generation products to target various forms of general or chronic pain such as back pain, arthritic pain and other orthopedic concerns. The company announced its first prototype in December. … Therma Bright’s attention to such a variety of skin care concerns positions it well within the cosmeceuticals market, which is expected to grow at a CAGR of 8.21 percent between 2017 and 2023, resulting in a worldwide market valued at $72.99 billion overall (http://nnw.fm/k91bY). ”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Therma Bright, Inc. (TBRIF) Stock Research Links
Scroll down for more posts ▼